BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.

ABSTRACT:

SUBMITTER: Lobo R 

PROVIDER: S-EPMC11759129 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature